neuro42 Announces the Closing of $6.5M Series A Round
neuro42 , the medical technology company leading the next evolution of MRI and robotics, today announced the close of a $6.5M Series A financing round.
- neuro42 , the medical technology company leading the next evolution of MRI and robotics, today announced the close of a $6.5M Series A financing round.
- Zepp Health led the financing round and is joined by ShangBay Capital and prominent angel investors, Krishna R. Bhupal and Philip Dolan.
- To date, the Company has raised $7.8M of which $1.3M was in an oversubscribed seed round that closed earlier this year.
- neuro42, Inc. is a San Francisco, CA based medical technology company focused on diagnostic imaging and image guided surgical interventions of the brain.